Ciliopathy due to POC1A deficiency: clinical and metabolic features, and cellular modeling

Archive ouverte

Perge, Kevin | Capel, Emilie | Villanueva, Carine | Gautheron, Jérémie | Diallo, Safiatou | Auclair, Martine | Rondeau, Sophie | Morichon, Romain | Brioude, Frédéric | Jéru, Isabelle | Rossi, Massimiliamo | Nicolino, Marc | Vigouroux, Corinne

Edité par CCSD ; Oxford Univ. Press -

International audience. Abstract Objective SOFT syndrome (MIM#614813), denoting Short stature, Onychodysplasia, Facial dysmorphism, and hypoTrichosis, is a rare primordial dwarfism syndrome caused by biallelic variants in POC1A, encoding a centriolar protein. SOFT syndrome, characterized by severe growth failure of prenatal onset and dysmorphic features, was recently associated with insulin resistance. This study aims to further explore its endocrinological features and pathophysiological mechanisms. Design/Methods We present clinical, biochemical, and genetic features of 2 unrelated patients carrying biallelic pathogenic POC1A variants. Cellular models of the disease were generated using patients' fibroblasts and POC1A-deleted human adipose stem cells. Results Both patients present with clinical features of SOFT syndrome, along with hyperinsulinemia, diabetes or glucose intolerance, hypertriglyceridemia, liver steatosis, and central fat distribution. They also display resistance to the effects of IGF-1. Cellular studies show that the lack of POC1A protein expression impairs ciliogenesis and adipocyte differentiation, induces cellular senescence, and leads to resistance to insulin and IGF-1. An altered subcellular localization of insulin receptors and, to a lesser extent, IGF1 receptors could also contribute to resistance to insulin and IGF1. Conclusions Severe growth retardation, IGF-1 resistance, and centripetal fat repartition associated with insulin resistance-related metabolic abnormalities should be considered as typical features of SOFT syndrome caused by biallelic POC1A null variants. Adipocyte dysfunction and cellular senescence likely contribute to the metabolic consequences of POC1A deficiency. SOFT syndrome should be included within the group of monogenic ciliopathies with metabolic and adipose tissue involvement, which already encompasses Bardet-Biedl and Alström syndromes.

Suggestions

Du même auteur

MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue

Archive ouverte | Capel, Emilie | CCSD

International audience

Lipodystrophic syndromes: From diagnosis to treatment

Archive ouverte | Sollier, Camille | CCSD

International audience. Lipodystrophic syndromes are acquired or genetic rare diseases, characterised by a generalised or partial lack of adipose tissue leading to metabolic alterations linked to strong insulin resi...

LIPE-related lipodystrophic syndrome: clinical features and disease modeling using adipose stem cells

Archive ouverte | Sollier, Camille | CCSD

International audience. Objective: The term Multiple Symmetric Lipomatosis (MSL) describes a heterogeneous group of rare monogenic disorders and multifactorial conditions, characterized by upper-body adipose masses....

Chargement des enrichissements...